Biomarkers in acute heart failure--state of the art. (Q38006640)

26 August 2017

title

Biomarkers in acute heart failure--state of the art. (English)

1 reference

acute decompensated heart failure

26 August 2017

0 references

0 references

1 reference

Alan S Maisel

1

1 reference

26 August 2017

Rajiv Choudhary

series ordinal

2

1 reference

26 August 2017

language of work or name

English

0 references

publication date

1 May 2012

1 reference

Nature Reviews Cardiology

26 August 2017

published in

1 reference

26 August 2017

volume

9

1 reference

26 August 2017

issue

8

1 reference

26 August 2017

page(s)

478-490

1 reference

Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Acute heart failure: multiple clinical profiles and mechanisms require tailored therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Acute heart failure: clinical presentation, one-year mortality and prognostic factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Clinical presentation, management and outcomes in the Acute Heart Failure Global Survey of Standard Treatment (ALARM-HF)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Pathophysiologic targets in the early phase of acute heart failure syndromes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Accuracy of B-type natriuretic peptide levels in the diagnosis of left ventricular dysfunction and heart failure: a systematic review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from Acute Decompensated Heart Failure National Registry (ADHERE)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Acute heart failure syndromes: clinical scenarios and pathophysiologic targets for therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Acute heart failure syndromes: emergency department presentation, treatment, and disposition: current approaches and future aims: a scientific statement from the American Heart Association.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

The pathophysiology of acute heart failure--is it all about fluid accumulation?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Prevalence of Negative Chest Radiography Results in the Emergency Department Patient With Decompensated Heart Failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Utility of B-natriuretic peptide in the evaluation of left ventricular diastolic function and diastolic heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Natriuretic peptides: Diagnostic and therapeutic use.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Diagnostic and prognostic usefulness of natriuretic peptides in emergency department patients with dyspnea

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Measurement and significance of circulating natriuretic peptides in cardiovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Structure, signaling mechanism and regulation of the natriuretic peptide receptor guanylate cyclase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Impact of age, race, and sex on the ability of B-type natriuretic peptide to aid in the emergency diagnosis of heart failure: results from the Breathing Not Properly (BNP) multinational study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

BNP as a marker of diastolic dysfunction in the general population: Importance of left ventricular hypertrophy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Natriuretic peptides and echocardiography in acute dyspnoea: implication of elevated levels with normal systolic function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

B-type natriuretic peptide: the level and the drug--partners in the diagnosis of congestive heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) progr

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

BNP at discharge in acute heart failure patients: is it all about volemia? A study using impedance cardiography to assess fluid and hemodynamic status

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Optimizing fluid management in patients with acute decompensated heart failure (ADHF): the emerging role of combined measurement of body hydration status and brain natriuretic peptide (BNP) levels.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

The usefulness of bioelectrical impedance analysis in differentiating dyspnea due to decompensated heart failure.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Use of BNP and bioimpedance to drive therapy in heart failure patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Bioimpedance vector analysis as a measure of muscle function.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Impedance vector distribution by sex, race, body mass index, and age in the United States: standard reference intervals as bivariate Z scores

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Diagnostic accuracy of B type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

B-type natriuretic peptide and amino terminal proBNP predict one-year mortality in short of breath patients independently of the baseline diagnosis of acute destabilized heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

NT-proBNP levels, echocardiographic findings, and outcomes in breathless patients: results from the ProBNP Investigation of Dyspnoea in the Emergency Department (PRIDE) echocardiographic substudy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Immunoluminometric assay for the midregion of pro-atrial natriuretic peptide in human plasma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Epidemiology and outcomes of acute renal failure in hospitalized patients: a national survey

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Worsening renal function and prognosis in heart failure: systematic review and meta-analysis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Renal impairment and outcomes in heart failure: systematic review and meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Acute kidney injury, mortality, length of stay, and costs in hospitalized patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Early diagnosis of acute kidney injury: the promise of novel biomarkers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Cardiorenal syndrome in acute decompensated heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Identification of Neutrophil Gelatinase-Associated Lipocalin as a Novel Early Urinary Biomarker for Ischemic Renal Injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated lipocalin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Neutrophil gelatinase-associated lipocalin as the real-time indicator of active kidney damage.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Biomarkers in acute and chronic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

NGAL: a biomarker of acute kidney injury and other systemic conditions.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Serum neutrophil gelatinase-associated lipocalin (NGAL) in predicting worsening renal function in acute decompensated heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: the NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Biomarkers of acute renal injury and renal failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Temporal relationship and predictive value of urinary acute kidney injury biomarkers after pediatric cardiopulmonary bypass

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Kidney injury molecule-1 correlates with kidney function in heart allograft recipients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Improved performance of urinary biomarkers of acute kidney injury in the critically ill by stratification for injury duration and baseline renal function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Diagnostic and prognostic stratification in the emergency department using urinary biomarkers of nephron damage: a multicenter prospective cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: findings from OPTIMIZE-HF.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Correlation of procalcitonin and C-reactive protein to inflammation, complications, and outcome during the intensive care unit course of multiple-trauma patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Serum procalcitonin measurement as diagnostic and prognostic marker in febrile adult patients presenting to the emergency department

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Can procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Procalcitonin Guidance of Antibiotic Therapy in Community-acquired Pneumonia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Procalcitonin in acute cardiac patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Procalcitonin in acute myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Expression and secretion of procalcitonin and calcitonin gene-related peptide by adherent monocytes and by macrophage-activated adipocytes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Useulness of B Natriuretic Peptides and Procalcitonin in Emergency Medicine.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Usefulness of procalcitonin as a marker of systemic infection in emergency department patients: a prospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Kinetics of procalcitonin in cardiogenic shock and in septic shock. Preliminary data

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Association of serum procalcitonin with cardiovascular prognosis in coronary artery disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Use of procalcitonin for the diagnosis of pneumonia in patients presenting with a chief complaint of dyspnoea: results from the BACH (Biomarkers in Acute Heart Failure) trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Serum surfactant protein-A levels in patients with acute cardiogenic pulmonary edema and adult respiratory distress syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Surfactant proteins-A and -B are elevated in plasma of patients with acute respiratory failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Elevated plasma surfactant protein-B predicts development of acute respiratory distress syndrome in patients with acute respiratory failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Prognostic value of surfactant proteins A and D in patients with acute lung injury.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Circulating surfactant protein-B levels increase acutely in response to exercise-induced left ventricular dysfunction.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Reliability of S100B in predicting severity of central nervous system injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Secretion of S-100 from rat C6 glioma cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Predicting outcome after severe traumatic brain injury using the serum S100B biomarker: results using a single (24h) time-point

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Outcome prediction in traumatic brain injury: comparison of neurological status, CT findings, and blood levels of S100B and GFAP.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Neuron-specific enolase, S100B, and glial fibrillary acidic protein levels as outcome predictors in patients with severe traumatic brain injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Elevated serum levels of S-100beta protein and neuron-specific enolase are associated with brain injury in patients with severe sepsis and septic shock

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Cerebral and extracerebral release of protein S100B in cardiac surgical patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

S100B interaction with the receptor for advanced glycation end products (RAGE): a novel receptor-mediated mechanism for myocyte apoptosis postinfarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

The receptor for advanced glycation endproducts (RAGE) and cardiovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Increased serum levels of S100B are related to the severity of cardiac dysfunction, renal insufficiency and major cardiac events in patients with chronic heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Copeptin, a fragment of the vasopressin precursor, as a novel predictor of outcome in heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

C-terminal provasopressin (copeptin) is associated with left ventricular dysfunction, remodeling, and clinical heart failure in survivors of myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Short-term mortality risk in emergency department acute heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Molecular forms of circulating adrenomedullin in patients with congestive heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Adrenomedullin, endothelin, neuropeptide Y, atrial, brain, and C-natriuretic prohormone peptides compared as early heart failure indicators

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Regulation of cardiac adrenomedullin in heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Mid-regional pro-adrenomedullin as a novel predictor of mortality in patients with chronic heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Prognostic value of mid-regional pro-adrenomedullin in patients with heart failure after an acute myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Increased plasma concentrations of soluble ST2 are predictive for 1-year mortality in patients with acute destabilized heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Serum levels of the interleukin-1 receptor family member ST2, cardiac structure and function, and long-term mortality in patients with acute dyspnea

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Galectin-3: a novel mediator of heart failure development and progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Galectin-3, cardiac structure and function, and long-term mortality in patients with acutely decompensated heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Improved diagnostic and prognostic performance of a new high-sensitive troponin T assay in patients with acute coronary syndrome.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

High sensitive troponin T and heart fatty acid binding protein: novel biomarker in heart failure with normal ejection fraction? A cross-sectional study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Evaluation of imprecision for cardiac troponin assays at low-range concentrations.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Recommendations for the use of cardiac troponin measurement in acute cardiac care

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Early diagnosis of myocardial infarction with sensitive cardiac troponin assays

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Cardiac troponin and outcome in acute heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

Serial changes in high-sensitive troponin I predict outcome in patients with decompensated heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.60

B-type natriuretic peptides: a diagnostic breakthrough for clinicians.

31 March 2020

1 reference

12 December 2020

Elevation of cardiac troponin I indicates more than myocardial ischemia

1 reference

12 December 2020

Biomonitoring and biomarker-guided therapy: the next step in heart failure and biomarker research

1 reference

12 December 2020

Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction. The Christchurch Cardioendocrine Research Group

1 reference

12 December 2020

Can troponin T replace CK MBmass as "gold standard" for acute myocardial infarction ("AMI")?

1 reference

12 December 2020

The renin-angiotensin aldosterone system: pathophysiological role and pharmacologic inhibition

1 reference

12 December 2020

Adrenomedullin in experimental congestive heart failure: cardiorenal activation

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRCARDIO.2012.60

1 reference

26 August 2017

1 reference